| 1 |
Napolitano LM. Sepsis 2018: definitions and guideline changes [J]. Surg Infect (Larchmt), 2018, 19(2): 117-125.
|
| 2 |
Marshall JC. Sepsis definitions: a work in progress [J]. Crit Care Clin, 2018, 34(1): 1-14.
|
| 3 |
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis 3) [J]. JAMA, 2016, 315(8): 801-810.
|
| 4 |
ProCESS Investigators, Yeal YDM, Kellum JA, et al. A randomized trial of protocol - based care for early septic shock [J]. N Engl J Med, 2014, 370(18): 1683-1693.
|
| 5 |
ARISE Investigators, ANZICS Clinical Trials Group, Peake SL, et al. Goal-directed resuscitation for patients with early septic shock [J]. N Engl J Med, 2014, 371(16): 1496-1506.
|
| 6 |
Mouncey PR, Osborn TM, Power GS, et al. Trial of early, goal- directed resuscitation for septic shock [J]. N Engl J Med, 2015, 372(14): 1301-1311.
|
| 7 |
Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock [J]. N Engl J Med, 2001, 345(19): 1368-1377.
|
| 8 |
Toweill D, Sonnenthal K, Kimberly B, et al. Linear and nonlinear analysis of hemodynamic signals during sepsis and septic shock [J]. Crit Care Med, 2000, 28(6): 2051-2057.
|
| 9 |
Goldston D. Big data: data wrangling [J]. Nature, 2008, 455(7209): 15.
|
| 10 |
Marik PE, Monnet X, Teboul JL. Hemodynamic parameters to guide fluid therapy [J]. Ann Intensive Care, 2011, 1(1): 1.
|
| 11 |
Monnet X, Pinsky MR. Predicting the determinants of volume responsiveness [J]. Intensive Care Med, 2015, 41(2): 354-356.
|
| 12 |
Vignon P, Repessé X, Vieillard-Baron A, et al. Critical care ultrasonography in acute respiratory failure [J]. Crit Care, 2016, 20(1): 228.
|
| 13 |
Zhou F, Peng Z, Murugan R, et al. Blood purification and mortality in sepsis: a meta-analysis of randomized trials [J]. Crit Care Med, 2013, 41(9): 2209-2220.
|
| 14 |
Park JY, An JN, Jhee JH, et al. Early initiation of continuous renal replacement therapy improves survival of elderly patients with acute kidney injury: a multicenter prospective cohort study [J]. Crit Care, 2016, 20(1): 260.
|
| 15 |
Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, CMA; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, CMA. Guideline for diagnosis and treatment of liver failure [J]. Chin J Clin Infect Dis, 2012, 5(6): 321-327.
|
| 16 |
Hayes RA, Shekar JF, Fraser J. Is hyperoxaemia helping or hurting patients during extracorporeal membrane oxygenation? review of a complex problem [J]. Perfusion, 2013, 28(3): 184-193.
|
| 17 |
Ostermann M, Connor M Jr, Kashani K. Continuous renal replacement therapy during extracorporeal membrane oxygenation: why, when and how?[J]. Curr Opin Crit Care, 2018, 24(6): 493-503.
|
| 18 |
Paek JH, Park S, Lee A, et al. Timing for initiation of sequential continuous renal replacement therapy in patients on extracorporeal membrane oxygenation [J]. Kidney Res Clin Pract, 2018, 37(3): 239-247.
|
| 19 |
Hernández G, Vaquero C, González P, et al. Effect of postextubation high-flow nasal cannula vs. conventional oxygen therapy on reintubation in low-risk patients: a randomized clinical trial [J]. JAMA, 2016, 315(13): 1354-1361.
|
| 20 |
Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure [J]. N Engl J Med, 2015, 372(23): 2185-2196.
|
| 21 |
Patel BK, Wolfe KS, Pohlman AS, et al. Effect of noninvasive ventilation delivered by helmet vs. face mask on the rate of endotracheal intubation in patients with acute respiratory distress syndrome: a randomized clinical trial [J]. JAMA, 2016, 315(22): 2435-2441.
|
| 22 |
Quartin AA, Schein RM, Kett DH, et al. Magnitude and duration of the effect of sepsis on survival. Department of veterans affairs systemic sepsis cooperative studies group [J]. JAMA, 1997, 277(13): 1058-1063.
|
| 23 |
Yende S, Linde-Zwirble W, Mayr F, et al. Risk of cardiovascular events in survivors of severe sepsis [J]. Am J Respir Crit Care Med, 2014, 189(9): 1065-1074.
|
| 24 |
Prescott HC, Langa KM, Liu V, et al. Increased 1-year healthcare use in survivors of severe sepsis [J]. Am J Respir Crit Care Med. 2014, 190(1): 62-69.
|
| 25 |
Wunsch H, Guerra C, Barnato AE, et al. Three-year outcomes for medicare beneficiaries who survive intensive care [J]. JAMA, 2010, 303(9): 849-856.
|
| 26 |
Paton M, Lane R, Hodgson CL. Early Mobilization in the Intensive Care Unit to Improve Long-Term Recovery [J]. Crit Care Clin, 2018, 34(4): 557-571.
|
| 27 |
Casserly B, Gerlach H, Phillips GS, et al. Evaluating the use of recombinant human activated protein C in adult severe sepsis: results of the Surviving Sepsis Campaign [J]. Crit Care Med, 2012, 40(5): 1417-1426.
|
| 28 |
Aikawa N, Takahashi T, Fujimi S, et al. A Phase Ⅱ study of polyclonal anti-TNF-α (AZD9773) in Japanese patients with severe sepsis and/or septic shock [J]. J Infect Chemother, 2013, 19(5): 931-940.
|
| 29 |
Lai PS, Thompson BT. Why activated protein C was not successful in severe sepsis and septic shock: are we still tilting at windmills? [J]. Curr Infect Dis Rep, 2013, 15(5): 407-412.
|
| 30 |
Yao YM, Luan YY, Zhang QH, et al. Pathophysiological aspects of sepsis: an overview [J]. Methods Mol Biol, 2015, 1237: 5-15.
|
| 31 |
Liu QY, Yao YM. Inflammatory response and immune regulation of high mobility group box-1 protein in treatment of sepsis [J]. World J Emerg Med, 2010, 1(2): 93-98.
|
| 32 |
刘辉，姚咏明. 皮质醇治疗与脓毒症:半个世纪的争论 [J]. 解放军医学杂志, 2015, 40(2): 92-96.
|
| 33 |
刘辉，姚咏明. 创伤脓毒症特点及救治对策 [J]. 国际外科学杂志, 2015, 42(11): 721-723.
|